Vein of Galen Malformation

Status: draft · Last updated 2026-11-03 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • What it is: choroidal arteries drain into a persistent median prosencephalic vein, which is not a true vein of Galen. Drainage is often through a falcine sinus, with an absent straight sinus .
  • Age shapes presentation: neonates with heart failure, infants with hydrocephalus and macrocephaly .
  • Hydrocephalus is from venous hypertension: embolize first, and shunt only if needed .
  • Treatment: staged transarterial embolization, timed by the Bicêtre score. About 62–68% have good outcomes and 10–14% die .
  • Neonates and heart failure do worst (48% good outcome vs 77% in infants) .
  • Fetal falcine sinus 7 mm or wider = high risk. In utero embolization is emerging but raises preterm delivery .
  • Genetics: RASA1 and EPHB4 .

Landmark papers

  • Bicêtre experience (Lasjaunias et al., Neurosurgery 2006): 216 treated patients. 10.6% died, and 74% of survivors were neurologically normal .
  • In utero embolization (Orbach et al., JAMA 2025): a falcine sinus 7 mm or wider identifies high-risk fetuses. Of 7 fetuses enrolled, 5 were embolized; 3 embolized children survived, all without developmental delay (overall mortality 43%), but 5 of 7 (71.4%) had unscheduled deliveries .

The vein of Galen malformation (VOGM, or vein of Galen aneurysmal malformation) is the most common congenital cerebrovascular anomaly . Choroidal arteries drain directly into a persistent, dilated median prosencephalic vein (the embryonic forerunner of the vein of Galen). This differs from a parenchymal AVM that drains into an already formed, dilated vein of Galen . The very high flow causes neonatal heart failure and venous hypertension, and it injures the developing brain.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:vogm:e32c3b312a09be02© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Midline sagittal view of an infant brain (anterior to the left): choroidal and pericallosal feeders converging on a dilated median prosencephalic vein, draining through a persistent falcine sinus to the superior sagittal sinus and torcula, with the straight sinus absentMIDLINE SAGITTAL (INFANT)anterior ←superior sagittal sinuspersistentfalcine sinustorculastraight sinus(often absent)venous pouch(prosencephalic vein)pericallosal(ACA) feederchoroidalfeederscorpuscallosum
Schematic midline sagittal view (anterior to the left). Choroidal and pericallosal feeders (red) converge on the dilated median prosencephalic vein (venous pouch), which drains through a persistent falcine sinus to the superior sagittal sinus and torcula. The straight sinus is often absent. Not to scale.

Anatomy and genetics

Presentation by age

Evaluation and selection

Treatment

Long-term outcome

Related topics

References

  1. Orbach DB, Shamshirsaz AA, Wilkins-Haug L, et al. In utero embolization for fetal vein of Galen malformation. JAMA 2025;334(10):878–885. doi:10.1001/jama.2025.12363. PMID 40788723. verified
  2. Lasjaunias PL, Chng SM, Sachet M, et al. The management of vein of Galen aneurysmal malformations. Neurosurgery 2006;59(5 Suppl 3):S184–S194. doi:10.1227/01.NEU.0000237445.39514.16. PMID 17053602. verified
  3. Chow ML, Cooke DL, Fullerton HJ, et al. Radiological and clinical features of vein of Galen malformations. J Neurointerv Surg 2015;7(6):443–448. doi:10.1136/neurintsurg-2013-011005. PMID 24789593. verified
  4. Zhao S, Mekbib KY, van der Ent MA, et al. Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. Nat Commun 2023;14(1):7452. doi:10.1038/s41467-023-43062-z. PMID 37978175. verified
  5. Duran D, Karschnia P, Gaillard JR, et al. Human genetics and molecular mechanisms of vein of Galen malformation. J Neurosurg Pediatr 2018;21(4):367–374. doi:10.3171/2017.9.PEDS17365. PMID 29350590. verified
  6. D'Amico A, Tinari S, D'Antonio F, et al. Outcome of fetal vein of Galen aneurysmal malformations: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022;35(25):5312–5317. doi:10.1080/14767058.2021.1878494. PMID 33508985. verified
  7. Taffin H, Maurey H, Ozanne A, et al. Long-term outcome of vein of Galen malformation. Dev Med Child Neurol 2020;62(6):729–734. doi:10.1111/dmcn.14392. PMID 31713850. verified
  8. Berenstein A, Fifi JT, Niimi Y, et al. Vein of Galen malformations in neonates: new management paradigms for improving outcomes. Neurosurgery 2012;70(5):1207–1213. doi:10.1227/NEU.0b013e3182417be3. PMID 22089754. verified
  9. Paramasivam S. Hydrocephalus in vein of Galen malformations. Neurol India 2021;69(Supplement):S376–S379. doi:10.4103/0028-3886.332279. PMID 35102992. verified
  10. Brinjikji W, Krings T, Murad MH, et al. Endovascular treatment of vein of Galen malformations: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2017;38(12):2308–2314. doi:10.3174/ajnr.A5403. PMID 28982789. verified
  11. McSweeney N, Brew S, Bhate S, et al. Management and outcome of vein of Galen malformation. Arch Dis Child 2010;95(11):903–909. doi:10.1136/adc.2009.177584. PMID 20605862. verified
  12. Yan J, Wen J, Gopaul R, et al. Outcome and complications of endovascular embolization for vein of Galen malformations: a systematic review and meta-analysis. J Neurosurg 2015;123(4):872–890. doi:10.3171/2014.12.JNS141249. PMID 26230476. verified
  13. Bhatia K, Mendes Pereira V, Krings T, et al. Factors contributing to major neurological complications from vein of Galen malformation embolization. JAMA Neurol 2020;77(8):992–999. doi:10.1001/jamaneurol.2020.0825. PMID 32338714. verified

Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. The Bicêtre score's individual components and cutoffs are not in the abstracts reviewed, so they are not given. The choroidal/mural type descriptions (many vs few feeders), the clinical signs listed for infants and the "elective embolization later in infancy" timing are standard teaching consistent with references 2 and 3. Reference 12's pooled sample includes a small proportion of children and adults (12%). The schematic is an original figure.